Sitabite M 50/500 mg Tablet 1*10

About Sitabite M 50/500 mg Tablet

Sitabite M 50/500 mg Tablet is an effective oral medication developed to manage type 2 diabetes mellitus in adults. This long-term condition arises when the body fails to produce enough insulin or becomes resistant to its action, resulting in elevated blood glucose levels. Without proper management, diabetes can lead to severe health issues such as kidney disease, heart complications, and nerve or eye damage.

This tablet combines two powerful antidiabetic agents — Vildagliptin and Metformin — that work synergistically to regulate blood sugar. Vildagliptin enhances insulin release from the pancreas and suppresses glucagon (a hormone that increases sugar levels), while Metformin lowers glucose production in the liver, delays sugar absorption in the intestines, and improves insulin sensitivity. Together, they ensure smooth and consistent control over blood sugar levels throughout the day.

Sitabite M 50/500 mg Tablet should be taken with meals to minimize gastrointestinal discomfort. It is usually prescribed once or twice daily, depending on the doctor’s evaluation of your blood sugar levels and treatment goals. Maintaining a balanced diet, regular exercise, and adherence to prescribed doses can significantly improve treatment outcomes.

Avoid stopping this medicine abruptly without consulting your doctor, as it may cause sudden fluctuations in blood sugar. Consistent use of Sitabite M 50/500 mg Tablet, along with proper lifestyle management, helps reduce the risk of diabetes-related complications.

Uses of Sitabite M 50/500 mg Tablet

• Control of Type 2 Diabetes Mellitus: Helps manage elevated blood sugar in adults whose diabetes is not adequately controlled by diet and exercise alone.
• Improves Glycemic Balance: Enhances insulin sensitivity and reduces glucose production by the liver for more stable sugar levels.
• Supports Weight Control: Helps manage weight by improving metabolism and reducing excess fat accumulation.
• Prevents Long-Term Complications: Regular use may lower the risk of diabetic nerve damage, kidney failure, and eye problems caused by uncontrolled sugar levels.

Medicinal Benefits

Sitabite M 50/500 mg Tablet provides dual-action glucose regulation through its unique combination of Metformin and Vildagliptin. Metformin improves how the body processes insulin, while Vildagliptin boosts insulin secretion after meals and decreases glucagon activity. This dual mechanism helps prevent blood sugar spikes and maintains steady glucose control throughout the day. It also supports better energy utilization, reduces fatigue, and helps maintain healthy body weight when used alongside diet and exercise.

How Sitabite M 50/500 mg Tablet Works

Sitabite M 50/500 mg Tablet effectively targets multiple aspects of blood sugar regulation.

• Metformin lowers sugar production in the liver, slows sugar absorption from the gut, and enhances insulin action in the body.
• Vildagliptin stimulates the pancreas to release more insulin in response to meals and suppresses excess glucagon release.
  By combining these mechanisms, Sitabite M 50/500 mg Tablet helps maintain optimal blood sugar levels both after meals and during fasting periods.

Directions for Use

• Take Sitabite M 50/500 mg Tablet with food to reduce the risk of stomach upset.
• Swallow the tablet whole with a glass of water — do not crush, chew, or break it.
• Take it at the same time every day to ensure consistent sugar control.
• Follow your doctor’s dosage instructions carefully; do not self-adjust or skip doses.

Possible Side Effects

While Sitabite M 50/500 mg Tablet is generally safe, some users may experience mild and temporary side effects such as:

• Nausea or diarrhea
• Headache or dizziness
• Indigestion or stomach pain
• Sweating, tiredness, or a metallic taste in the mouth
• Low blood sugar (hypoglycemia), especially when combined with other antidiabetic medicines

Seek medical attention if you experience severe symptoms or persistent discomfort.

Safety Advice & Precautions

• Avoid alcohol consumption, as it may increase the risk of lactic acidosis and affect blood sugar control.
• This medicine is not suitable for patients with type 1 diabetes, severe kidney or liver disease, or diabetic ketoacidosis.
• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
• If you are undergoing any X-ray or dye-based diagnostic test, temporarily stop taking this medicine as advised by your doctor.
• Monitor your kidney, liver, and thyroid function regularly during prolonged use.
• Do not discontinue the medicine without consulting your healthcare provider.

Storage Instructions

Store Sitabite M 50/500 mg Tablet in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.

Overdose Information

If you accidentally take more than the prescribed dose, contact your doctor or go to the nearest hospital immediately. Symptoms of overdose may include weakness, confusion, sweating, or dizziness.

Diet & Lifestyle Tips

• Follow a balanced diet rich in fiber, vegetables, and whole grains.
• Avoid foods high in sugar, refined carbs, and saturated fats.
• Engage in at least 150 minutes of moderate exercise weekly.
• Maintain a healthy body weight and stay hydrated.
• Avoid smoking and manage stress through meditation or yoga.
• Regularly monitor your blood sugar and blood pressure to track your progress.

Product Variants & Keywords:

Sitabite M 50/500 mg Tablet, Sitabite M Tablet, Sitabite M 50/500 Diabetes Control Tablet, Sitabite M Metformin Vildagliptin Tablet, Sitabite M 50/500 for Type 2 Diabetes Management.